Iboga in the United States · IN
Iboga and ibogaine in Indiana
Indiana's 2025-27 budget expanded its therapeutic psilocybin research fund to include ibogaine, with $300,000 listed per fiscal year.
Status
Law enacted
$300,000
State research funding
1
Bills tracked
October 26, 2026
Last checked
Where Indiana stands
Indiana's 2025 budget bill, HB 1001, expanded the Therapeutic Psilocybin Research fund (created in 2024) to cover ibogaine and community mental health center participation. Research institutions may seek funding for studies in PTSD, depression, anxiety, chronic pain and substance use disorders, with emphasis on veterans and first responders. Budget documents list $300,000 in dedicated funds for each of FY2025-26 and FY2026-27.
A law touching ibogaine or iboga is on the books.
Funding: $300,000. $300,000 dedicated funds per fiscal year, FY2025-26 and FY2026-27, per budget summary.
Timeline
State-backed research under way through the fund
Axios Indianapolis reports the fund, administered by the Division of Mental Health and Addiction, is backing an Indiana University psilocybin trial for veterans and first responders; the budget adds $300,000 a year for ibogaine research.
Source: Axios Indianapolis
Governor signs the 2025-27 budget
Gov. Mike Braun signed House Enrolled Act 1001, the two-year state budget that carries the Therapeutic Psilocybin and Ibogaine Research fund.
Source: Indiana Capital Chronicle
HB 1001 budget adds ibogaine to research fund
Summary of HB 1001 describes a therapeutic psilocybin and ibogaine research fund for institution-led clinical studies, focused on veterans and first responders.
Source: Citizen Portal (cpo.soar.com)
Budget lists $300,000 per year for the fund
Budget summary lists the Therapeutic Psilocybin and Ibogaine Research fund at $300,000 in dedicated funds for FY2025-26 and for FY2026-27.
Source: Citizen Portal (cpo.soar.com)
Bills
| Bill | Title | Status |
|---|---|---|
| HB 1001 (2025) | State biennial budget; includes Therapeutic Psilocybin and Ibogaine Research fund | Enacted; signed by Gov. Mike Braun on 2025-05-06 |
Who is involved
- Indiana General Assembly
Official legislature site hosting HB 1001 (2025) bill record.
Legislators and legislative offices
- Indiana Division of Mental Health and Addiction
Administers the Therapeutic Psilocybin Research Fund, which the 2025 budget expanded to include ibogaine research.
Government agencies
For Indiana residents: a whole root ceremony on Kauaʻi
Vital Kauaʻi is a legally established church on Kauaʻi’s North Shore. Members from Indiana join a thirteen-week journey: six weeks of preparation from home, one week on the island with two held nights with the whole root in ceremony, and six weeks of integration after. Guides, a medical provider, somatic practitioners and integration coaches walk with each member through all of it.
Preparation, from Indiana
A medical consultation and health review, somatic and nervous-system preparation, and weekly guidance through the member portal. All of it happens from home, on Zoom, before travel.
Ceremony, on Kauaʻi
Two nights with the whole root in nature, one-on-one or in a container of up to three, with experienced guides and the medical provider present overnight. An EKG on-island comes first.
Integration, back in Indiana
Six weekly one-on-one calls with an integration coach, plus somatic sessions, so what the root shows you becomes how you live, lead and create at home.
Book a discovery callThirty minutes on Zoom. We meet you, and you share what is calling you.
In the news, video and podcasts
News, videos and podcasts that name Indiana appear here as Iboga Worldwide gathers it, daily.
Every state
How this tracker is kept
- Each state is checked against legislature records, agency releases and published reporting, and carries the date it was last checked. Every development links to its source.
- “No known activity” means the state was checked on the date shown and no ibogaine-specific law, bill, funding or task force was found.
- The directory lists organizations and public offices with their own websites. Listing points readers to them and does not endorse them.
- This tracker is offered for education and does not constitute legal or medical advice. Ibogaine and iboga remain Schedule I substances under federal law. See the medical disclaimer.
- To share a development or request a correction, write to aloha@vitalkauai.com. For daily coverage, see Iboga Worldwide.